Articles by Leonard Pogach, MD, MBA
Facility Variation in Utilization of Angiotensin-converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Patients With Diabetes Mellitus and Chronic Kidney Disease
ByAnjali Tiwari, MBBS, MS,Chin-Lin Tseng, DrPH,Elizabeth F. O. Kern, MD,Miriam Maney, MA, CHPQ,Donald R. Miller, ScD,Leonard Pogach, MD, MBA Diabetes Healthcare Quality Report Cards: How Accurate Are the Grades?
ByLeonard Pogach, MD, MBA,Minge Xie, PhD,Yue Shentue, BA,Chin-Lin Tseng, DrPH,Miriam Maney, MA,Mangala Rajan, MBA,Anjali Tiwari, MD,John Kolassa, PhD,Drew Helmer, MD,Stephen Crystal, PhD,Monika Safford, MD Impact of Policies and Performance Measurement on Development of Organizational Coordinating Strategies for Chronic Care Delivery
ByLeonard Pogach, MD, MBA,Martin P. Charns, DBA,James S. Wrobel, DPM, MS,Jeffrey M. Robbins, DPM,Kristin M. Bonacker, BA,Linda Haas, PhC, RN, CDE,Gayle E. Reiber, MPH, PhD